ALGS

ALGS

USD

Aligos Therapeutics Inc. Common Stock

$7.070+0.870 (14.032%)

Real-time Price

Healthcare
Biotechnology
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$6.200

High

$7.170

Low

$6.200

Volume

0.12M

Company Fundamentals

Market Cap

49.1M

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

0.08M

Exchange

NCM

Currency

USD

52-Week Range

Low $3.76Current $7.070High $46.8

Related News

GlobeNewswire

Aligos Therapeutics to Present at Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (NASDAQ:ALGS) a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies

View more
Aligos Therapeutics to Present at Upcoming Investor Conferences
GlobeNewswire

Aligos Therapeutics to Announce 3rd Quarter 2025 Financial Results on November 6, 2025

SOUTH SAN FRANCISCO, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (NASDAQ:ALGS), a clinical stage biotechnology company focused on improving patient outcomes through best-in-class therapies for

View more
Aligos Therapeutics to Announce 3rd Quarter 2025 Financial Results on November 6, 2025